Name | Pomotrelvir |
---|
Description | Pomotrelvir (PBI-0451) is a selective, orally active SARS-CoV-2 3CL protease inhibitor. Pomotrelvir has antiviral activity and can be used in the research of novel coronavirus (COVID-19)[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C23H26ClN5O3 |
---|---|
Molecular Weight | 455.94 |